Vagus nerve stimulation (VNS) for the treatment of patients with drug refractory epilepsy by stimulation of the nerve responsible for relaying messages between the brain and certain parts of the body. That way, VNS Therapy helps control the type of brain activity that often leads to seizures without any brain surgery.
With VNS the patient feel fewer and less
severe seizures, shorter recovery time from seizures, improved mood & decrease in dose or number of epilepsy medications.
VNS is also efficient for treatment of chronic drug refractory depression patients.
Impulse Dynamics - CCM
Cardiac Contractility Modulation (CCM) is an innovative technology for treating moderate to severe heart failure, by delivering non-excitatory electrical pulses to the heart.
Research has shown that CCM signals significantly improve the heart’s contractility by modifying the function and expression of certain proteins in the heart muscle and, through that, the function of the heart.
In fact, CCM is the only treatment that actually trains the heart.
European Clinical trials have shown that chronic CCM treatment is safe and significantly improves exercise tolerance and quality of life in symptomatic heart failure patients with normal QRS duration.
Abilia - EMFIT
The top selling seizure muscle contraction monitor and currently in use in over 60 countries worldwide. The Emfit MM is clinically proven technology for monitoring an individual who, during sleep, may experience faster, abnormal muscle jerkings that continue 10 seconds or longer. A quick, high-frequency alert allows a caregiver or family member ample time to respond. Easy to install, and no false alarms that can lead to user fatigue.
Elminda - BNA SYSTEM
BNA™ system combines EEG-technology with big-data analytics and machine learning to quantify and visualize brain network functionality. Applying advanced algorithms, including digital-signal processing, graph theory, clustering analysis, and pattern recognition, BNA™ immediately uncovers multidimensional patterns of brain activity and shows them clearly and effectively like never before. BNA™ has the power to identify neuromarkers related to specific cognitive domains (i.e., working memory, attention, motor, and sensory domains) allowing diagnosis and monitoring of healthy patients and those suffering from brain-related disorders (e.g., Depression, Alzheimer's disease, traumatic brain injury and Parkinson's